<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR166">
 <label>166.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beig</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Lindley</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Dahan</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Striking the optimal solubility-permeability balance in oral formulation development for lipophilic drugs: maximizing Carbamazepine blood levels</article-title>
  <source>Mol Pharm</source>
  <year>2017</year>
  <volume>14</volume>
  <issue>1</issue>
  <fpage>319</fpage>
  <lpage>327</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.6b00967</pub-id>
  <?supplied-pmid 27981848?>
  <pub-id pub-id-type="pmid">27981848</pub-id>
 </element-citation>
</ref>
